1. The long persistence of pyrrolizidine alkaloid-derived pyrrole-protein adducts in vivo: Kinetic study following multiple exposures of a pyrrolizidine alkaloid containing extract of Gynura japonica
- Author
-
Changhong Wang, Aizhen Xiong, Li Yang, Fen Xiong, Weiqian Wang, Yan Chen, Gang Deng, Kaiyuan Jiang, Xuanling Ye, and Zhengtao Wang
- Subjects
Male ,0301 basic medicine ,food.ingredient ,Pyrrolizidine alkaloid ,Hepatic Veno-Occlusive Disease ,Blood stasis ,Pharmacology ,Toxicology ,Japonica ,Mice ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,food ,In vivo ,Animals ,Pyrroles ,Pyrrolizidine Alkaloids ,biology ,Plant Extracts ,Blood Proteins ,General Medicine ,biology.organism_classification ,Mice, Inbred C57BL ,Kinetics ,030104 developmental biology ,Liver ,chemistry ,Herb ,Pyrrolizidine ,Toxicity ,030217 neurology & neurosurgery ,Drugs, Chinese Herbal ,Blood sampling - Abstract
Gynura japonica (also named Tusanqi in Chinese) is used as a folk herbal medicine for treating blood stasis or traumatic injury. However, hundreds of hepatic sinusoidal obstruction syndrome (HSOS) cases have been reported after consumption of preparations made from G. japonica because it contains large amounts of hepatotoxic pyrrolizidine alkaloids (PAs). To date, blood pyrrole-protein adducts (PPAs) are suggested as biomarkers for the diagnosis of PA-induced HSOS in clinics. However, the concentration of PPAs in the blood is greatly affected by several factors including the amount of PA exposure, herb intake period, and blood sampling time after the last exposure. In present study, the kinetic characters of PPAs in serum and liver as well as other potential target organs were studied systematically and comprehensively following multiple exposures of PAs in G. japonica extract (GJE). As results, PPAs content reached to a plateau both in serum and liver after the mice were treated with GJE for 2 weeks on daily basis. PPAs cleared significantly slower in liver (T1/2ke∼184.6 h, ∼7.7 days) than in serum (T1/2ke∼95.8 h, ∼4.0 days). Although more than 90 % PPAs were removed 2 weeks after the last dosing, PPAs still persisted in the liver until the end of the experiment, i.e. 8 weeks after the last dosing. The results would be of great help for understanding the importance of PPAs for PA-induced toxicity and its detoxification.
- Published
- 2020